PharmaMar opens subsidiary in UK
PharmaMar abre una filial en Reino Unido
Intel ID : 229359
| Synopsis |
|
Spain-based PharmaMar, a subsidiary of Spain-based Zeltia (BME: ZEL), opened a subsidiary in the United Kingdom, as published by Zeltia through a relevant fact issued by the Securities Commission CNMV on 15 September 2015. With this transaction, PharmaMar, a biopharmaceutical company engaged in research, development and marketing of sea-based drugs to fight cancer, will be present in the UK, Italy, Germany, France, Switzerland and Spain.
(content in spanish)
La empresa española PharmaMar, filial de la también española Zeltia (BME: ZEL), ha llevado a cabo la apertura de una filial en Reino Unido, según ha comunicado Zeltia en un hecho relevante remitido a la Comisión Nacional del Mercado de Valores (CNMV) el 15 de septiembre de 2015. Tras la apertura PharmaMar, empresa biofarmacéutica dedicada a descubrir, desarrollar y comercializar nuevos medicamentos de origen marino contra el cáncer, contará con presencia en Reino Unido, Italia, Alemania, Francia, Suiza y España. |
Relevant Documents
| Notice / Relevant Fact | 15 Sep 2015 | Zeltia_Hecho_Relevante_2015.pdf | ES |
|
| Intel ID | 229359 | |
| Value | ND | |
| Native Currency | Euro (EUR) | |
|
Financial Data - PharmaMar
(31 Dec 2021) |
Revenue: - EBITDA: - Net Debt: - |
|
| Date |
 |
|
| Country | |
|
| Region | ||
| Continent |  |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.01 Biopharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Ultimate Owner (Buyer)
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
25.04.03 Holding Companies / Financial Holding Companies 25 Financial Services / 25.04 Other Financial Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.